Stay updated on HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.

Latest updates to the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check45 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check52 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check73 days agoChange DetectedThe website has updated the intervention type information to include a verified entry from Harbour BioMed, while removing the previous version details.SummaryDifference3%
- Check102 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBM4003 Combo with Anti-PD-1: Safety & Efficacy Clinical Trial page.